Financials
- Market Capitalization 344.86 M
- Employee 81
- Founded 1999
- CEO N/A
- Website www.agenusbio.com
- Headquarter Delaware, United States
- FIGI BBG000C8SWQ9
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
—
Fiyat/satışlar oranı
0.82
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 3173 | LYEL Lyell Immunopharma, Inc. - Common Stock | 14.53 USD | -0.55% | -5.03% | +7.63% | -39.93% | 356.06 M USD | ||
| 3190 | PALI Palisade Bio, Inc. - Common Stock | 2.00 USD | -5.21% | -4.31% | +3.09% | +17.65% | 348.54 M USD | ||
| 3200 | SABS SAB Biotherapeutics, Inc. - Common Stock | 3.79 USD | -3.56% | +1.07% | +6.46% | +83.98% | 344.84 M USD | ||
| 3201 | DMAC DiaMedica Therapeutics Inc. - Common Stock | 6.39 USD | -5.33% | -2.14% | -1.84% | +11.91% | 344.59 M USD |